1. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. (2006) Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Journal of Women's Health 15(1):57-69.
   
2. Freeman EW, Rickels K, Sammel MD, Lin H, Sondheimer SJ. (2009) Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. Archives of General Psychiatry. 66(5):537-544.
   
3. Gold EB, Bair Y, Block G, Greendale GA, Harlow SD, Johnson S, Kravitz HM, Rasor MO, Siddiqui A, Sternfeld B, Utts J, Zhang G. (2007) Diet and lifestyle factors associated with premenstrual symptoms in a racially diverse community sample: Study of Women's Health Across the Nation (SWAN). Journal of Women's Health. (5):641-656.
   
4. Dennehy CE. (2006) The use of herbs and dietary supplements in gynecology: an evidence-based review. Journal of Midwifery and Women's Health. 51(6):402-409.
   
5. Canning S, Waterman N, Dye L. (2006) Dietary supplements and herbal remedies for premenstrual syndrome (PMS): a systematic research review of the evidence for their efficacy. Journal of Reproductive and Infant Psychology. 24(4):363-378.
   
6. Ahmad MK, et al. (2009) Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertilitly and Sterility.
   
7. Al-Qarawi AA, et al. (2000) The effect of extracts of Cynomorium coccineum and Withania somnifera on gonadotrophins and ovarian follicles of immature Wistar rats. Phytotherapy Research. 14(4):288-290.
   
8. Malik F, et al. (2009) Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. European Journal of Cancer. 45(8):1494-1509.
   
9. Mulabagal V, et al. (2009) Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytotherapy Research. 23(7):987-992.
   
10. Stan SD, et al. (2008) Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Research. 68(18):7661-7669.
    
11. Winters M. (2006) Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Alternative Medicine Reviews. 11(4):269-277.
    
12. Kaileh M, et al. (2007) Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. Journal of Biological Chemistry. 282(7):4253-4264.
    
13. Kour K, et al. (2009) Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A. International Immunopharmacology.
    
14. Bhattacharya SK, et al. (2000) Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 7(6):463-469.
    
15. Bhattacharya SK, Muruganandam AV. (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacology and Biochemistry of Behavior. 75(3):547-555.
    
16. Kulkarni SK, Singh K, Bishnoi M. (2008) Comparative behavioural profile of newer antianxiety drugs on different mazes. Indian Journal of Experimental Biology. 46(9):633-638.
    
17. van der Hooft CS, et al. (2005) Thyrotoxicosis following the use of ashwagandha. Ned Tijdschr Geneeskd. 149(47):2637-8.
    
18. Schellenberg R. (2001). Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. British Medical Journal. 322(7279):134-137
    
19. Berger D, Schaffner W, Schrader E, Meier B, Brattstr�m A. (2000). Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet. 264(3):150-153.
    
20. Daniele C, Thompson Coon J, Pittler MH, Ernst E. (2005). Vitex agnus castus: a systematic review of adverse events. Drug Safety. 28(4):319-332.
    
21. Mayo J.L. (1998). A Healthy Menstrual Cycle. Clinical Nutrition Insights. 5(9):1-8.
    
22. Jarboe CH, Schmidt CM, Nicholson JA, Zirvi KA. (1966). Uterine relaxant properties of Viburnum. Nature. 212(5064):837.
    
23. Westfall R.E. (2008). Herbal medicine in pregnancy and childbirth. Advances in Therapy. 18(1):47-55.
    
24. Bayles BP. (2007) Herbal and other complementary medicine use by Texas midwives. Journal of Midwifery and Women's Health. 52(5):473-478.
    
25. Rojas-Vera J, Patel AV, Dacke CG. (2002) Relaxant activity of raspberry (Rubus idaeus) leaf extract in guinea-pig ileum in vitro. Phytotherapy Research. 16(7):665-668.
    
26. (2008) Herbal remedies for dyspepsia: peppermint seems effective. Prescrire Int. 17(95):121-123.
    
27. Vo LT, Chan D, King RG. (2003) Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clinical and Experimental Pharmacology and Physiology. 30(10):799-804.
    
28. Fintelmann V, Gruenwald J. (2007) Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Advances in Therapy. 24(4):929-39.
    
29. Maslova LV, Kondrat'ev BI, Maslov LN, Lishmanov IB. (1994) The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksp Klin Farmakol. 57:61-63.
    
30. Lazarova MB, Petkov VD, Markovska VL, et al. (1986) Effects of meclofenoxate and Extr. Rhodiolae roseae L. on electroconvulsive shock-impaired learning and memory in rats. Methods and Findings in Experimental and Clinical Pharmacology. 8:547-552.
    
31. Darbinyan V, Kteyan A, Panossian A, et al. (2000) Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 7:365-371.
    
32. Spasov AA, Wikman GK, Mandrikov VB, et al. (2000) A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine.7:85-89.
    
33. Lishmanov IB, Trifonova ZV, Tsibin AN, et al. (1987) Plasma beta-endorphin and stress hormones in stress and adaptation. Biull Eksp Biol Med. 103:422-424.
    
34. Stancheva SL, Mosharrof A. (1987) Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monamines. Medical Physiology. 40:85-87.
    
35. Baranov AI. (1982) Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. Journal of Ethnopharmacology. 6:339-353.